Germany · Investor

TVM Capital

Last cheque observed Apr 2024. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietPrivate equity

SeedSeries ASeries BPsychedelicsGene TherapyTherapeutic

Cheques on record
0%of best year0cheques in 12 months, 81 on record
Since the last cheque943days00hrs00min00sec
Median round$25MRounds led1 of 81Sole investor5 roundsExits13 from the portfolioMostly inUnited States, 53%
Pitch TVM Capital

TVM Capital highlights

  1. 01

    81 rounds on record

  2. 02

    Mostly Venture and Series B: 53% of its rounds

  3. 03

    Sole investor in 5 rounds, median $1.6M

  4. 04

    13 exits from the portfolio

What they do

TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
PsychedelicsGene TherapyTherapeutic
Based in
Munich, Germany
Cold pitches
Not stated

The record

Every round we can evidence, newest first81 appearances

  1. 2024

    1 round

  2. Apr
    Smart ReportingSeries C · DE · Firms' own news pages$25MLed
  3. 2015

    4 rounds

  4. Jul
    leon nanodrugsSeries A · DE$20MWith 4 others
  5. Apr
    Rapid Micro BiosystemsSeries C · US$25MWith 5 others
  6. Apr
    Esperas PharmaUndisclosedWith 1 other
  7. Jan
    CoLucid PharmaceuticalsSeries C · US$37MWith 7 others
  8. 2014

    5 rounds

  9. Aug
    FAAH PharmaUndisclosedSole investor
  10. Jun
    DefiniensVenture · DE$20MWith 2 others
  11. May
    Proteon TherapeuticsSeries D · US$45MWith 9 others
  12. Apr
    Rapid Micro BiosystemsVenture · US$6.0MWith 4 others
  13. Mar
    invendo medicalVenture · US$28MWith 3 others
  14. 2013

    3 rounds

  15. Aug
    IxchelsisGrowth · GB · finsmes.comUndisclosedSole investor
  16. Jun
    Rapid Micro BiosystemsSeries B · US · finsmes.com$33MWith 4 others
  17. Jan
    Kaneq BioscienceCA · marketwatch.comUndisclosedSole investor
  18. 2012

    4 rounds

  19. Oct
    DefiniensVenture · DE · finsmes.com$13MWith 1 other
  20. Jul
    bluebird bioSeries D · US · in.finance.yahoo.com$60MWith 6 others
  21. Apr
    Argos TherapeuticsSeries D · US · argostherapeutics.com$25MWith 4 others
  22. Jan
    ProbiodrugVenture · DE · finsmes.com$19MWith 5 others
  23. 2011

    2 rounds

  24. Apr
    bluebird bioVenture · US · live-pr.com$30MWith 4 others
  25. Apr
    F-star Biotechnology LimitedVenture · AT · f-star.com$22MWith 6 others
  26. 2010

    7 rounds

  27. Dec
    Cambridge Broadband NetworksVenture · GB · finsmes.com$17MWith 4 others
  28. Aug
    Anchor TherapeuticsSeries B · US · anchortx.com$10MWith 2 others
  29. Jul
    Cerenis TherapeuticsSeries C · FR · cerenis.com$52MWith 6 others
  30. Apr
    DIREVO Industrial BiotechnologySeries D · DE · onbiovc.com$8.1MWith 1 other
  31. Mar
    VPIsystemsVenture · US$4.0MWith 4 others
  32. Mar
    bluebird bioSeries B · US · fiercebiotech.com$35MWith 4 others
  33. Feb
    DIREVO Industrial BiotechnologyVenture · DE · direvo.com$8.3MWith 1 other
  34. 2009

    6 rounds

  35. Nov
    ProbiodrugSeries B · DE · probiodrug.de$54MWith 7 others
  36. Aug
    UbidyneSeries B · US · freshnews.com$43MWith 3 others
  37. Aug
    Rapid Micro BiosystemsSeries A · US · onbiovc.com$19MWith 3 others
  38. May
    Proteon TherapeuticsSeries B · US · proteontherapeutics.com$50MWith 7 others
  39. Feb
    Cambridge Broadband NetworksVenture · GB · totaltele.com$7.5MWith 3 others
  40. Jan
    Revolt TechnologySeries B · US$13MWith 6 others
  41. 2008

    12 rounds

  42. Dec
    Extend MediaSeries C · US · newteevee.com$10MWith 2 others
  43. Oct
    Silicon HiveVenture · NL · eetimes.com$7.0MWith 2 others
  44. Sept
    CommProveVenture · IE · commprove.com$14MWith 2 others
  45. Aug
    SpePharmVenture · NL · spepharm.com$39MWith 2 others
  46. Aug
    BitWaveSeries B · US · marketwatch.com$10MWith 2 others
  47. May
    ArterisSeries C · US · venturebeat.com$7.5MWith 4 others
  48. May
    Winbox TechnologiesSeries A · DE · eetimes.com$1.6MSole investor
  49. Apr
    Concert PharmaceuticalsSeries C · US$37MWith 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed13 in all

DefiniensBought by MedImmune$150MNov 2014
bluebird bioListed$101MJun 2013
IntercellBought by VivalisUndisclosedDec 2012
NetviewerBought by Citrix OnlineUndisclosedDec 2010
Extend MediaBought by Cisco$80MAug 2010
CoreOpticsBought by Cisco$99MMay 2010
VPIsystemsBought by Elanti SystemsUndisclosedMar 2010
DIREVO Industrial BiotechnologyBought by Bayer HealthCare$297MSept 2008
JeriniBought by Shire$554MJul 2008
Sirtris PharmaceuticalsBought by GlaxoSmithKline$720MApr 2008
Arrow TherapeuticsBought by AstraZenecaUndisclosedFeb 2007
TissueInformaticsBought by BioImagineUndisclosedJun 2006
TissueInformaticsBought by IcoriaUndisclosedMar 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as TVM Capital. A count of rooms they were both in, not a relationship either has claimed.

Skyline VenturesVC firm8rounds togetherAccelVC firm6rounds togetherAtlas VentureVC firm6rounds together3i GroupPrivate equity5rounds togetherAmadeus Capital PartnersVC firm4rounds togetherCrescendo VenturesGrowth equity4rounds togetherEaston CapitalVC firm4rounds togetherForbion Capital PartnersPrivate equity4rounds togetherGimvPrivate equity4rounds togetherIntersouth PartnersVC firm4rounds togetherKleiner Perkins Caufield & ByersVC firm4rounds togetherQuaker PartnersVC firm4rounds together

Recently backed

The latest companies TVM Capital put money into.

Smart Reporting$25M · Apr 2024

Quick answers about TVM Capital

What does TVM Capital invest in?

TVM Capital invests most often at Venture and Series B (53% of the rounds on record), in sectors such as Psychedelics, Gene Therapy and Therapeutic.

How active is TVM Capital?

81 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Apr 2024.

What has TVM Capital invested in recently?

Its most recent investments on record: Smart Reporting (Series C, Apr 2024).

How big are TVM Capital's cheques?

The median round it joins is $25M.

Does TVM Capital lead rounds?

Sometimes: it led 1 of its 81 investments on record (1%).

Where does TVM Capital invest?

Most of the companies it backs are in the United States (53%), Germany (24%) and the United Kingdom (8%).

Is TVM Capital investing now?

No investments in the last 12 months; the latest was in Apr 2024.

Who does TVM Capital invest alongside?

Most often Skyline Ventures (8 rounds together), Accel (6 rounds together) and Atlas Venture (6 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it